FDA unveils system to facilitate patient meeting requests

FDA launched a new system to make it easier for non-industry stakeholders -- such as patient advocacy groups and providers -- to request drug-related meetings with the agency's Center for Drug Evaluation and Research, according to a tweet from FDA Commissioner Scott Gottlieb Friday morning.

"Previously, requestors often wrote to various people within [FDA's] CDER until they were sent to the correct point of contact and personnel within CDER," FDA spokesperson Jeremy Kahn told BioCentury...